Naproxen Tablet
Product Images NDC 65862-521

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 65862-521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (250 mg (100 Tablets Bottle))

Package Label-principal Display Panel (250 mg (100 Tablets Bottle))
This is a description of a medication bottle containing Naproxen Tablets USP with a strength of 250mg. There are 100 tablets in the bottle and the recommended dosage is indicated in the package insert. It is advised to store the tablets between 20 to 25 degrees Celsius. The medication should be dispensed in tamper-evident containers with a medication guide provided separately. The medication is distributed by Aurobindo Pharma USA, Inc. from their location at 273 Princeton Hightstown Road, East Windsor, WI 08520. The country of manufacture is India. There is also a cautionary note not to be pinned on the bottle.*
FDA Label Image

Package Label-principal Display Panel (250 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (250 mg Blister Carton (10 x 10 Unit-dose))
This is a description for Naproxen Tablets USP manufactured by Aurobindo Pharma USA, Inc. Each tablet contains 250 mg Naproxen USP. The usual dosage should be consulted in the package insert. The tablets are stored at 20° to 25°C (68° to 77°F) in a light-resistant container. The unit-dose package is tamper-evident, and a child-resistant container should be used for outpatient use. The distribution of the product is done in the USA, and it is made in India. There is also a code present on the packaging - TS/DRUGS/22/2009 4.*
FDA Label Image

Package Label-principal Display Panel (375 mg (100 Tablets Bottle))

Package Label-principal Display Panel (375 mg (100 Tablets Bottle))
This is a description of Naproxen tablets, a prescription drug. Each tablet contains 375 mg of Naproxen USP. The package contains 100 tablets, and the usual dosage can be found in the insert. The tablets must be stored at a temperature between 20°-25°C (68°-77°F), and dispensed in a tamper-evident container. The medication guide is provided separately. The drug is distributed by Aurobindo Pharma USA, Inc. and made in India. Information beyond the medication itself appears to be missing or not available from the output.*
FDA Label Image

Package Label-principal Display Panel (500 mg (100 Tablets Bottle))

Package Label-principal Display Panel (500 mg (100 Tablets Bottle))
This is a description of a drug labeled "Rx Only" with the NDC code 65862-522-01. The drug is Naproxen Tablets USP and each tablet contains 500mg of Naproxen. The package includes 100 tablets and a medication guide that should be dispensed separately. The drug should be stored at 20°-25°C (68°-77°F) in light-resistant containers. It is distributed by Aurobindo Pharma USA, Inc. and made in India. The code TS/DRUGS/22/2009 can be found on the package.*
FDA Label Image

Chemical Structure (Naproxen Str)

Chemical Structure (Naproxen Str)
Naproxen is a medication that belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is represented by the chemical formula R-COOH and has the molecular formula C14H14O3. The remaining text "OHO" is not readable and seems to be an error in the process.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.